AB Vista is an animal nutrition technology company offering pioneering products and technical services to the global animal feed industry. With its headquarters in the UK, the company employs over 190 staff globally and has support offices worldwide.
Helping you assess feed quality to make smarter nutritional and commercial decisions.
Helping you measure enzyme activity to ensure consistent quality control.
Helping you optimise the feed manufacturing process.
AB Vista is committed to facilitating discussions around animal nutrition technology and gathering experts to provide independent opinions.
Our ultimate aim is to research and apply science that brings real value commercially to the animal production industry.
Stay ahead with the latest news, ideas and events.
AB Vista is committed to bringing new ways of thinking to the global feed industry. Our work attracts enquiring minds who see things differently and embrace the changing landscape – offering our clients an interested, innovative and up-to-date partner.
Wednesday, March 14, 2018
Feed is the largest expense in poultry production, accounting for 60 - 70% of costs. With a wide range of commercially available enzymes to choose from, there are many factors to consider when evaluating cost effectiveness and return on investment – not least whether to use a multi or single NSP enzyme.
At IPPE, Dr Tara York NAM Technical Manager presented the findings of a competitive study looking at the cost effectiveness of three different enzyme programmes, based around dispelling the belief that a multiple NSP product when combined with a phytase provides an advantage over a single NSP enzyme.
As Dr York outlines in the video, it is important that any enzyme comparison is based not just on up-front feed cost savings, but also on liveability, feed conversion and body weight gain. The study used average live broiler cost per pound (lb) of meat as the determination of which combination was most effective overall since this is the parameter the industry looks at the most in the US.
The result of this study, when compared in an economic model, demonstrated that the Econase XT + Quantum Blue programme led to the lowest live cost per pound of meat. In addition this led to the Econase XT+ Quantum Blue program profiting over $3 million when compared to the treatment with the lowest feed cost overall.
For the overall value extracted from the birds in terms of lbs of meat, FCR, BW etc, when you looked at the live bird margin*, the Econase XT + Quantum Blue program profited over $6 million on a million bird per week complex compared to the control.
*live bird margin = (Income- cost), with cost including chick cost, feed cost
Read AB Vista's insights from IPPE 2018
A regular summary of our key stories sent straight to your inbox
© AB Vista. All rights reserved 2018